Severe gastrointestinal inflammation in adult dermatomyositis: Characterization of a novel clinical association

American Journal of the Medical Sciences

Volumn 332, Issue 6, 2006, Pages 308-313

  Tweezer Zaks, Nurit ^a   Ben Horin, Shomron ^a,b   Schiby, Ginette ^a   Bank, Ilan ^a   Levi, Yair ^a   Livneh, Avi ^a   Langevitz, Pnina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Dermatomyositis; Gastrointestinal; Perforation; Vascular ecstasies; Vasculopathy

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FOLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; ANTIBIOTIC THERAPY; APHERESIS; ARTICLE; BLOODY DIARRHEA; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DIGESTIVE SYSTEM INFLAMMATION; DIGESTIVE SYSTEM PERFORATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; EDEMA; EROSION; FATALITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPEREMIA; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE MUCOSA; INTESTINE ULCER; INTESTINE WALL; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; PARENTERAL NUTRITION; POLYMYOSITIS; PREVALENCE; PROGNOSIS; RARE DISEASE; RECURRENT DISEASE; RETROSPECTIVE STUDY; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH BIOPSY; VASCULITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; FATAL OUTCOME; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; HYDROXYCHLOROQUINE; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; METHOTREXATE; PREDNISOLONE;

EID: 33845796552     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200612000-00003     Document Type: Article

References (38)

1. Spiera R, Kagen L. Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheumatol 1998;10:556-61.
2. Pasquier E, Wattiaux MJ, Peigney N. First case of pneumatosis cystoides intestinalis in adult DM. J Rheumatol 1993;20:499-503.
3. Coup MO, Barnard ML, Stamp G, et al. Ulcerative ileojejunitis associated with pulmonary fibrosis and polymyositis. Hepatogastroenterology 1988;35:144-6.
4. Kleckner FS. Dermatomyositis and its manifestations in the gastrointestinal tract. Am J Gastroenterol 1970;53:141-6.
5. Suwa A, Hirakata M, Hama N, et al. An adult case of dermatomyositis complicated with cecum perforation and panniculitis. Nihon Rinsho Meneki Gakkai Kaishi 1997;20:60-6.
6. Niizawa M, Maie O, Asanuma Y, et al. Adult DM with angiopathy and cecum perforation. Nipon Hifuka Gakkai Zasshi 1991;101:447-51.
7. Eshraghi N, Farahmand M, Maerz LL, et al. Adult onset DM with severe gastrointestinal manifestations: Case report and review of the literature. Surgery 1998;123:356-8.
8. Kurihara Y, Ikari H, Saito N, et al. Recurrent ischemic colitis in dermatomyositis. Rishno Hoshasen 1983;28:1523-6.
9. Swenson WM, Witkowsky LJ, Roskelley RC. Total colectomy for dermatomyositis. Am J Surg 1968;115:405-407.
10. Gennaro AR, Bacon HE. Dermatomyositis and associated lesions of the gastrointestinal tract. Dis Colon Rectum 1969;12:256-60.
11. Sofat N, Pitcher M, Price A, et al. A case of weak muscles. Ann Rheum Dis 2002;61:10-12.
12. Schullinger JN, Jacob JC, Berdon WE. Diagnosis and management of gastrointestinal perforations in childhood dermatomyositis with particular reference to perforations of the duodenum. J Pediatr Surg 1985;20:521-4.
13. Musaev SN, Novikova AV, Klimanskaia EV, et al. Endoscopic and morphometric characteristics of gastric and duodenal mucosa in children with dermatomyositis. Clin Reumatol 1991:21-5.
14. Magill HL, Hixson SD, Whitington G, et al. Duodenal perforation in childhood DM. Pediatr Radiol 1984;14:28-30.
15. Wang IJ, Hsu WM. Juvenile dermatomyositis complicated with vasculitis and duodenal perforation. J Formos Med Assoc 2001;100:844-6.
16. Takeda T, Fujisaku A. Fatal vascular occlusion in juvenile dermatomyositis. Ann Rheum Dis 1998;57:172-6.
17. Falcini F, Trapani S, Ermini M, et al. Systemic vasculitis in juvenile dermatomyositis: a fatal case. Clin Exp Rheumatol 1995;13:531-2.
18. Lee FD. Drug related pathological lesions of the intestinal tract. Histopathology 1994;25:303-8.
19. Colin-Jones DG. Drug induced gastrointestinal ulceration: a review. J R Soc Med 1980;73:46-7.
20. Piper JM, Ray WA. Corticosteroid use and peptic ulcer. Ann Intern Med 1991;114:735-40.
21. Bauriedel G, Schwaiblamair M. Spontaneous hemothorax in DM and long standing glucocorticoid treatment. Dtsch Med Wochenschr 1995;120:209-13.
22. Rooney PJ, Hunt RH. The risk of upper GI hemorrhage during steroid and non steroidal anti inflammatory therapy. Baillieres Clin Rheumatol 1991;4:207-17.
23. Sartori S, Trevisani L. Misoprostol and omeprazol in the prevention of chemotherapy induced mucosal injury. Cancer 1996;78:1477-82.
24. Cappell MS, Simon T. Colonic toxicity of administered medications and chemicals. Am J Gastroenterol 1993;88:1684-99.
25. Singh G, Fries JF. Toxicity profiles of DMARDs in RA. J Rheumatol 1991;18:188-94.
26. Marie I, Levesque H, Cailleux N, et al. Intravenous immunoglobulin for treatment of gastro-intestinal hemorrhage in dermatomyositis. Ann Rheum Dis 2000;60:723-4.
27. Marie I, Hachulla E, Levesque H,. Intravenous immunoglobulins as a treatment of life threatening esophageal involvement in poly and dermatomyositis. J Rheum 1999;26:2706-9.
28. Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high dose intravenous immunoglobulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
29. Gottlieb. Intravenous immunoglobulin increases risk of thrombotic events. BMJ 2002;324-1056.
30. Harkness KA, Goulding P. Central retinal vein occlusion complicating treatment with intravenous immunoglobulin. Eye 2000;14:662-3.
31. Elkayam O, Paran D, Milo R, et al. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders: a study of four cases. Ann Rheum Dis 2000;59:77-80.
32. Stange EF, Travis SPL, Vermeire S, for the European Crohn's and Colitis Organisation (ECCO). European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55 Suppl 1:i1-15.
33. Feldman D, Hochbrg MC, Zizic TM, et al. Cutaneous vasculitis in adult with DM. J Rheum 1983;10:85-9.
34. Hunger RE, Durr C, et al. Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy. Dermatology 2001;202:123-6.
35. Ghali FE, Stein LD, Fine JD, et al. Gingival telangiectases: an underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol 1999;135:1370-4.
36. Marie I, Levesque H, Cailleux N, et al. Intravenous immunoglobulin for treatment of gastro-intestinal haemorrhage in dermatomyositis. Ann Rheum Dis 2001;60:723-4.
37. Kissel JT, Mendell JR. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:329-33.
38. Kissel JT, Halterman RK. The relationship of complement mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol 1991;48:26-31.